Remus Pharmaceuticals Limited IPO
Remus Pharmaceuticals Limited was a SME IPO in the Pharmaceuticals sector, offered at ₹1,150–₹1,229 per share to raise ₹48 crore. It listed on 29 May 2023 at ₹1,711 and closed its first day at ₹1,797, a listing gain of +46.2% versus the ₹1,229 issue price. It now trades around ₹843 (-31.4% versus the issue price).
Frequently asked questions
- What were the Remus Pharmaceuticals Limited IPO listing gains?
- Remus Pharmaceuticals Limited listed on 29 May 2023 at ₹1,711, closing its first day at ₹1,797 — a listing gain of +46.2% versus the ₹1,229 issue price.
- What was the price band and lot size of the Remus Pharmaceuticals Limited IPO?
- The price band was ₹1,150–₹1,229 per share, with a minimum lot of 100 shares (₹1,22,900 at the upper band).
- Who were the registrar and lead manager for the Remus Pharmaceuticals Limited IPO?
- Link Inime India Private limited was the registrar, and Beeline Capital Advisors was the book-running lead manager.